| Unique ID issued by UMIN | UMIN000026788 |
|---|---|
| Receipt number | R000030751 |
| Scientific Title | Photodynamic diagnosis (PDD) of Peritoneal disseminations of gastric cancer using intraoperative fluorescence laparoscopy with 5-ALA administration. |
| Date of disclosure of the study information | 2017/04/01 |
| Last modified on | 2019/04/01 17:36:56 |
Photodynamic diagnosis (PDD) of Peritoneal disseminations of gastric cancer using intraoperative fluorescence laparoscopy with 5-ALA administration.
Photodynamic diagnosis of Peritoneal disseminations of gastric cancer with 5-ALA.
Photodynamic diagnosis (PDD) of Peritoneal disseminations of gastric cancer using intraoperative fluorescence laparoscopy with 5-ALA administration.
Photodynamic diagnosis of Peritoneal disseminations of gastric cancer with 5-ALA.
| Japan |
gastric cancer
| Gastroenterology | Gastrointestinal surgery |
Malignancy
NO
To evaluate a photodynamic diagnostic power for peritoneal dissemination of gastric cancer with 5-aminolevulinic acid.
Efficacy
Exploratory
Pragmatic
Not applicable
Additive effect to a photodynamic diagnostic power for peritoneal dissemination of gastric cancer with 5-ALA.
Sensitivity, specificity, positive predictive value, negative predictive value of examination for peritoneal disseminated malignant nodules from primary gastric cancer using photodynamic diagnosis with 5-ALA.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Diagnosis
| Medicine |
5-aminolevulinic acid(5-ALA) is administered orally, 3-4 hours before start of an operation. Under general (and epidural) anesthesia and peumoperitoneum with carbon dioxide gas, laparoscopic examination is performed intraabdominally with blue-light exciting fluorescence and white-light. Observed by white-light only, blue-light only, and both white and blue-light, peritoneal nodules are snapshooted and counted. Some of them are excisional biopsied and confirmed their pathological diagnoses to compare with their photodynamic diagnoses.
| 20 | years-old | <= |
| 85 | years-old | >= |
Male and Female
Patients who have advanced gastric cancer with serosal invasion and scheduled a staging laparoscopy or a curative gastric resection.
Patients who signed informed consent.
Porphyria.
A history of photosensitivity.
Taking drugs that may cause photosensitivity.
Patients are judged to be inappropriate to participate in this study for any reason by the investigators.
20
| 1st name | Kazuhiro |
| Middle name | |
| Last name | Imamura |
Tokyo Metropolitan Tama Medical Center
Department of Surgery
183-8524
2-8-29 Musashidai, Fuchu-shi, Tokyo, Japan
042-323-5111
imamurakazu@mac.com
| 1st name | Kazuhiro |
| Middle name | |
| Last name | Imamura |
Tokyo Metropolitan Tama Medical Center
Department of Surgery
183-8524
2-8-29 Musashidai, Fuchu-shi, Tokyo, Japan
042-323-5111
imamurakazu@mac.com
Tokyo Metropolitan Tama Medical Center
Tokyo Metropolitan Government
Local Government
Tokyo Metropolitan Tama Medical Center
2-8-29 Musashidai, Fuchu-shi, Tokyo, Japan
0423235111
Kaori_Murase@member.metro.tokyo.jp
YES
H280502001
Tokyo Metropolitan Government
102
東京都立多摩総合医療センター
| 2017 | Year | 04 | Month | 01 | Day |
Unpublished
12
Completed
| 2016 | Year | 01 | Month | 12 | Day |
| 2016 | Year | 01 | Month | 14 | Day |
| 2016 | Year | 09 | Month | 01 | Day |
| 2018 | Year | 08 | Month | 31 | Day |
| 2017 | Year | 03 | Month | 30 | Day |
| 2019 | Year | 04 | Month | 01 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030751